SI
CDMO

Stephens Inc’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Stephens Inc’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-311,405
Closed -$3.85M – 1328
2024
Q4 		$3.85M Sell
311,405
-18,340
-6% -$210K 0.05% 309
2024
Q3 		$3.75M Sell
329,745
-4,018
-1% -$40.3K 0.05% 313
2024
Q2 		$2.38M Buy
333,763
+10,568
+3% +$80.8K 0.04% 395
2024
Q1 		$2.17M Buy
323,195
+69,827
+28% +$480K 0.03% 409
2023
Q4 		$1.65M Buy
253,368
+97,037
+62% +$625K 0.03% 437
2023
Q3 		$1.48M Buy
156,331
+27,338
+21% +$329K 0.03% 449
2023
Q2 		$1.8M Sell
128,993
-27,373
-18% -$467K 0.03% 404
2023
Q1 		$2.93M Buy
156,366
+40,072
+34% +$658K 0.06% 311
2022
Q4 		$1.6M Buy
116,294
+567
+0.5% +$8.69K 0.03% 415
2022
Q3 		$2.21M Buy
115,727
+1,012
+0.9% +$18.4K 0.05% 339
2022
Q2 		$1.75M Buy
114,715
+12,519
+12% +$185K 0.04% 414
2022
Q1 		$2.08M Buy
102,196
+13,853
+16% +$282K 0.03% 417
2021
Q4 		$2.58M Sell
88,343
-24,963
-22% -$714K 0.04% 402
2021
Q3 		$2.44M Sell
113,306
-42,239
-27% -$1.02M 0.04% 416
2021
Q2 		$3.99M Sell
155,545
-1,150
-0.7% -$24.6K 0.06% 322
2021
Q1 		$2.86M Sell
156,695
-5,196
-3% -$86.3K 0.05% 378
2020
Q4 		$1.87M Buy
161,891
+7,413
+5% +$67.8K 0.03% 446
2020
Q3 		$1.18M Buy
154,478
+82,275
+114% +$623K 0.02% 511
2020
Q2 		$474K Buy
72,203
+33,478
+86% +$187K 0.01% 716
2020
Q1 		$198K Buy
38,725
+2,239
+6% +$13.6K 0.01% 894
2019
Q4 		$280K Buy
+36,486
New +$213K 0.01% 896

Other funds holding CDMO

TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Stephens Inc's CDMO Position: Q1 2025 in Review

Stephens Inc sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 311,405 shares — an estimated $3.85M sold.

Stephens Inc first reported a position in CDMO in Q4 2019 and held it in 21 quarters. The position peaked at $3.99M in Q2 2021. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.

  • Stephens Inc reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • Stephens Inc sold 311,405 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $3.85M.
  • Stephens Inc first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2019 and held it in 21 quarters.
  • Stephens Inc's Avid Bioservices, Inc. Common Stock position peaked at $3.99M in Q2 2021.
  • 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.

Based on Stephens Inc's 13F filing for Q1 2025, filed 1 May 2025.